You sat across from your oncologist expecting the next treatment plan, and instead heard the words "there's nothing more we can do." The floor drops out.

Dr. Bharat Patodiya was in his Pune consulting room when the scans arrived. A patient in Jodhpur had triple-negative breast cancer.

Your mother has received a metastatic breast cancer diagnosis. The words feel final, but the treatment plan does not have to be.

You are sitting with a printed oncology file that uses words you never expected to read, and you are supposed to trust the roadmap inside it with your life.

When multiple myeloma returns, choosing the right next-line therapy requires specialized expertise. A second opinion from a myeloma-focused center helps confirm your treatment plan, explore clinical trials, and access novel therapies like CAR-T. Key Takeaways Second opinions for relapsed myeloma are most valuable from dedicated myeloma programs at academic centers with high case volume and clinical trial portfolios US centers like Mayo Clinic, Dana-Farber, and Cleveland Clini